Portland Research Site Marked 50 Years of Progress
The Headlands Research Summit Portland reflects on a half-century of clinical trials, including work on dementia treatments.
Updated on Oct. 12, 2026 in Alzheimer’s
In 2026, the Headlands Research Summit Portland celebrated its 50th anniversary of conducting clinical trials. The facility has played a long-standing role in advancing medical research for local residents and beyond.
Why it matters
The site provides critical local access to clinical trials for complex conditions, helping move new therapies from the research phase to potential FDA approval.
Over five decades, the facility has supported every FDA-approved class of Alzheimer's disease medication since 1993. The center manages a high volume of clinical research, including 75 trials focused on Alzheimer's and 150 on other central nervous system disorders.
The players
Headlands Research Summit Portland
A clinical research facility that investigates vaccines, diabetes, obesity, and central nervous system conditions.
Dr. Scott Losk
A researcher who has served as a principal investigator on over 75 clinical trials for Alzheimer's disease.
The details
The facility partners with pharmaceutical companies to evaluate new medical treatments across various therapeutic areas. Through its Memory Health Centre, the site conducts specialized clinical research for dementia, employing methodologies that have supported decades of neurological drug development.
Timeline
1976: The facility was founded in Portland.
1990: Dr. Scott Losk began practicing at the facility.
1993: Facility research supported the first Alzheimer's drug class.
2026: The facility celebrated its 50th anniversary.
Health Landscape
The center functions as a long-standing contributor to the clinical research ecosystem that informs the FDA drug approval pathway for Alzheimer's disease. Its work helps bridge the gap between early-stage drug development and final clinical application for central nervous system conditions.
Clinical trials offer residents opportunities to participate in the study of new therapies for dementia and other chronic conditions. If you are managing a condition like Alzheimer's, discussing the role of clinical trials with your doctor is a practical way to evaluate potential care options.
The takeaway
The facility's 50-year history highlights the ongoing evolution of neurological treatment research in the community. When considering new treatment avenues, ask your physician if current clinical trials are appropriate for your specific health profile.
Further reading
For more on current research and care, visit our Alzheimer’s section.
Source note: This article includes information reported by Scientist Live.
